Mouroux J - Search Results

1

Use of circulating tumor cells in prospective clinical trials for NSCLC patients - standardization of the pre-analytical conditions.

Ilie M, Hofman V, Leroy S, Cohen C, Heeke S, Cattet F, Bence C, Lalvée S, Mouroux J, Marquette CH, Hofman P; STALKLUNG01 and AIR Study Consortium Investigators. Ilie M, et al. Among authors: mouroux j. Clin Chem Lab Med. 2018 May 24;56(6):980-989. doi: 10.1515/cclm-2017-0764. Clin Chem Lab Med. 2018. PMID: 29397019

2

Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.

Sanfiorenzo C, Ilie MI, Belaid A, Barlési F, Mouroux J, Marquette CH, Brest P, Hofman P. Sanfiorenzo C, et al. Among authors: mouroux j. PLoS One. 2013;8(1):e54596. doi: 10.1371/journal.pone.0054596. Epub 2013 Jan 16. PLoS One. 2013. PMID: 23342174 Free PMC article.

3

"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease.

Ilie M, Hofman V, Long-Mira E, Selva E, Vignaud JM, Padovani B, Mouroux J, Marquette CH, Hofman P. Ilie M, et al. Among authors: mouroux j. PLoS One. 2014 Oct 31;9(10):e111597. doi: 10.1371/journal.pone.0111597. eCollection 2014. PLoS One. 2014. PMID: 25360587 Free PMC article.

4

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

Ilie M, Long E, Butori C, Hofman V, Coelle C, Mauro V, Zahaf K, Marquette CH, Mouroux J, Paterlini-Bréchot P, Hofman P. Ilie M, et al. Among authors: mouroux j. Ann Oncol. 2012 Nov;23(11):2907-2913. doi: 10.1093/annonc/mds137. Epub 2012 Jun 26. Ann Oncol. 2012. PMID: 22735679 Free article.

5

Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis.

Ilie MI, Hofman V, Ortholan C, Ammadi RE, Bonnetaud C, Havet K, Venissac N, Mouroux J, Mazure NM, Pouysségur J, Hofman P. Ilie MI, et al. Among authors: mouroux j. Int J Cancer. 2011 Apr 1;128(7):1614-23. doi: 10.1002/ijc.25491. Epub 2010 Jun 2. Int J Cancer. 2011. PMID: 20521252 Free article.

6

Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma.

Ilie MI, Hofman V, Bonnetaud C, Havet K, Lespinet-Fabre V, Coëlle C, Gavric-Tanga V, Vénissac N, Mouroux J, Hofman P. Ilie MI, et al. Among authors: mouroux j. Virchows Arch. 2010 Oct;457(4):483-95. doi: 10.1007/s00428-010-0963-z. Epub 2010 Aug 28. Virchows Arch. 2010. PMID: 20803030

7

Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker.

Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, Mourad N, Butori C, Selva E, Poudenx M, Sibon S, Kelhef S, Vénissac N, Jais JP, Mouroux J, Molina TJ, Hofman P. Hofman V, et al. Among authors: mouroux j. Clin Cancer Res. 2011 Feb 15;17(4):827-35. doi: 10.1158/1078-0432.CCR-10-0445. Epub 2010 Nov 23. Clin Cancer Res. 2011. PMID: 21098695

8

Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay™ and the isolation by size of epithelial tumor cell method.

Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, Molina T, Vénissac N, Mouroux J, Vielh P, Hofman P. Hofman V, et al. Among authors: mouroux j. Int J Cancer. 2011 Oct 1;129(7):1651-60. doi: 10.1002/ijc.25819. Epub 2011 Mar 11. Int J Cancer. 2011. PMID: 21128227 Free article.

9

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

Hofman VJ, Ilie MI, Bonnetaud C, Selva E, Long E, Molina T, Vignaud JM, Fléjou JF, Lantuejoul S, Piaton E, Butori C, Mourad N, Poudenx M, Bahadoran P, Sibon S, Guevara N, Santini J, Vénissac N, Mouroux J, Vielh P, Hofman PM. Hofman VJ, et al. Among authors: mouroux j. Am J Clin Pathol. 2011 Jan;135(1):146-56. doi: 10.1309/AJCP9X8OZBEIQVVI. Am J Clin Pathol. 2011. PMID: 21173137

10

Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.

Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coëlle C, Mouroux J, Hofman P. Ilie M, et al. Among authors: mouroux j. Cancer. 2012 Mar 15;118(6):1726-37. doi: 10.1002/cncr.26456. Epub 2011 Aug 25. Cancer. 2012. PMID: 21953630 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page